Further Study Indicated for Follicular Lymphoma Vaccine

Submitted by mike Wed 07/27/2005

Share on Tumblr

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Genitope today announced that its independent Data Safety Monitoring Board (DSMB) reviewed the first planned interim analysis of data for efficacy in its pivotal Phase 3 clinical trial for treatment of follicular non-Hodgkin's Lymphoma (fNHL) and recommended that the trial continue as planned. People watching the study hoped that success and wrap-up of the trial would indicate moving forward with FDA approval.

The trial evaluates the safety and effectiveness of the MyVax(R) Personalized Immunotherapy in patients with previously untreated fNHL. The trial compares patients treated with MyVax(R) Personalized Immunotherapy to patients treated with a nonspecific immunotherapy control.

The next interim analysis of data for efficacy is now scheduled to occur in mid-2006.

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Support Groups

SupportGroups.com

For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Cancer Support Groups

Find a Treatment Facility Near You

Click on a state below to find Lymphoma treatment options that could be right for you.

Select a State Below

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.